Although mitogen-activated protein kinase (MAPK) was shown to be activated by CD99 silencing in Ewing sarcoma (Rocchi et al., 2010), GDF6 silencing still induced p21 when the MAPK pathway was suppressed by a MEK inhibitor, PD98059 (Figure S4C). This evidence concerns the gene MAP2K7 and Ewing sarcoma.